These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14451410)

  • 1. [The properdin level in normal subjects and in some pathological conditions].
    JASSER S; BRAGIEL I; LEWENFISZ T; BORKOWSKI MT; MASZCZYK Z
    Pol Tyg Lek; 1961 Aug; 16():1267-70. PubMed ID: 14451410
    [No Abstract]   [Full Text] [Related]  

  • 2. [The "properdin system" and some stomatologic affections. X. Behavior of the serum properdin level in subjects with sialolithiasis].
    CHIARAVALLE N
    Boll Soc Ital Biol Sper; 1962 Sep; 38():835-6. PubMed ID: 14020767
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of properdin in normal subjects and patients with renal disease.
    Ziegler JB; Rosen FS; Alper CA; Grupe W; Lepow IH
    J Clin Invest; 1975 Sep; 56(3):761-7. PubMed ID: 1159085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOME OBSERVATIONS IN RELATION TO PROPERDIN SYSTEM. IV. RELATION OF SERUM COMPLEMENT ACTIVITY AND PROPERDIN LEVEL OF NORMAL ALBINO RATS TO STREPTOMYCIN THERAPY AND DIET.
    SEN R; MATHUR PD; MAJUMDAR AC
    Ann Biochem Exp Med; 1963 Dec; 23():577-82. PubMed ID: 14154202
    [No Abstract]   [Full Text] [Related]  

  • 5. [The properdin system in normal and pathological tissue].
    MARQUES P; DOUSTE-BLAZY L; PUEL J
    Bull Assoc Fr Etud Cancer; 1962; 49():84-93. PubMed ID: 14470153
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathological variations of complement and properdin in man].
    SOULIER JP; MENACHE D
    Acta Haematol; 1958; 20(1-4):260-74. PubMed ID: 13582572
    [No Abstract]   [Full Text] [Related]  

  • 7. THE CLINICO-PATHOLOGICAL SIGNIFICANCE OF THE VARIABILITY OF THE SERUM-PROPERDIN-LEVEL IN TUMORS.
    NAGY IS; KOSZORU M; MAJOROSSY K; VAJDA J
    Acta Unio Int Contra Cancrum; 1964; 20():1241-3. PubMed ID: 14274746
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on properdin. Note 1. Properdin and changes in blood properdin levels in various disease conditions].
    SILVESTRI G; FONNESU V
    Riforma Med; 1960 Jul; 74():793-9. PubMed ID: 14446788
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental studies on the properdin system of the rabbit. (III). On changes in the properdin titer under varying conditions].
    YAMAMASU N
    Nihon Saikingaku Zasshi; 1961 Oct; 16():873-6. PubMed ID: 14008819
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bactericidal activity of normal and low-properdin sera and of properdin-zymosan complexes].
    SZEMERE G
    Kiserl Orvostud; 1963 Feb; 15():58-61. PubMed ID: 13979914
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison between properdin titers obtained in the zymosan assay and in the bacterio-phage-neutralization assay. 2. Investigation on pathological sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():419-28. PubMed ID: 14414557
    [No Abstract]   [Full Text] [Related]  

  • 12. [The properdin titer in women with labor pathology or gynecological disease and the role of this titer in the prognosis].
    Malkov JJ
    Zentralbl Gynakol; 1975; 97(17):1047-56. PubMed ID: 1189778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the level of properdin in normal adult humans and in certain disease states.
    NEWCOMER VD; McNALL EG; HALDE C; WRIGHT ET; STERNBERG TH
    J Invest Dermatol; 1958 May; 30(5):233-6. PubMed ID: 13549796
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of activation of the properdin system. Studies on properdin electrophoretic mobility in agarose activation of the alternative pathway.
    Adam C; Williams DG; Peters DK
    Clin Exp Immunol; 1975 Nov; 22(2):240-8. PubMed ID: 813932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative measurement of properdin in normal human serum by electroimmunoassay and single radial immunodiffusion.
    Persson K; Kindmark CO; Pensky J; Naff G
    Clin Exp Immunol; 1977 Jul; 29(1):84-8. PubMed ID: 408067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The properdin system and antibody formation. I. The serum properdin level in rabbits during immunization with Mycobacterium tuberculosis].
    WAHLIG H
    Arch Mikrobiol; 1959; 32(2):127-37. PubMed ID: 13628083
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan].
    FUMAROLA D; MODICA F
    Tumori; 1959; 45(1):46-53. PubMed ID: 13659609
    [No Abstract]   [Full Text] [Related]  

  • 18. [Properdin system: properdin level in children].
    FUMAROLA D
    Boll Ist Sieroter Milan; 1958; 37(1-2):87-91. PubMed ID: 13536005
    [No Abstract]   [Full Text] [Related]  

  • 19. [The "properdin system" and some stomatologic affections. IX. Relation between the serum properdin level and some forms of benign neoplasms of the oral cavity].
    PETTINI PL
    Boll Soc Ital Biol Sper; 1962 Sep; 38():833-4. PubMed ID: 13942987
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH; Townsend K; Michael AF
    Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.